Molecular knockdown and pharmacological inhibition of AQP1 in colon cancer cells significantly impaired migration, supporting AQP1 as a candidate target for colon cancer therapy [118,119,120,121,122,123]. This evidence concerns the gene AQP1 and malignant colon neoplasm.